Knowing your peptide-pathway genetics removes guesswork from GLP-1 selection and dosing
As a result, many individuals experience faster and more substantial weight loss compared to single-pathway treatments
This means these formulations do not undergo the same rigorous testing for safety, efficacy, and quality that brand-name medications like Ozempic or Wegovy require
These include reducing oxidative stress caused by surgery and anesthetics, enhancing immunity, and reducing swelling, inflammation, and bruising
So, exogenous GLP-1R agonists have been more recently considered as a good choice for treating patients with diabetes [29]
This is particularly important for those with conditions like type 2 diabetes or metabolic syndrome, as proper guidance and monitoring can help achieve better results.